Laureus Capital is a venture capital firm founded in 2014 and based in Hamburg, Germany. The firm is composed of a group of entrepreneurs who focus on investing in companies within the technology, artificial intelligence, and biotechnology sectors. Through its investments, Laureus Capital aims to support innovative businesses that are at the forefront of technological advancements.
Impossible Cloud offers a decentralized, enterprise-grade cloud platform leveraging web3 technology. It provides faster, cheaper, and more secure multi-service solutions compared to traditional hyperscalers and on-premises private clouds. Backed by a fiat-based payment system, it caters to B2B customers without requiring cryptocurrency transactions. The platform ensures 100% durability and availability with almost unlimited storage capacity and no hidden costs.
Impossible Cloud
Seed Round in 2023
Impossible Cloud offers a decentralized, enterprise-grade cloud platform leveraging web3 technology. It provides faster, cheaper, and more secure multi-service solutions compared to traditional hyperscalers and on-premises private clouds. Backed by a fiat-based payment system, it caters to B2B customers without requiring cryptocurrency transactions. The platform ensures 100% durability and availability with almost unlimited storage capacity and no hidden costs.
ETHRIS
Series B in 2022
Ethris GmbH is a biotechnology company based in Planegg, Germany, specializing in the development of innovative therapeutic solutions for diseases with unmet medical needs. The company has a focus on transcript therapeutics, particularly through its SNIM RNA platform, which offers a novel approach to treating various conditions by enabling the production of therapeutic proteins within the patient’s body. This platform presents an alternative to traditional recombinant protein and gene therapies, addressing a range of diseases, including rare and genetically predetermined conditions. Ethris also develops Magnetovax, a personalized tumor vaccine platform that utilizes magnetic fields for localized activation in tumors. The company has established strategic research collaborations with major pharmaceutical firms, enhancing its capabilities in regenerative medicine and therapeutic development. Founded in 2009, Ethris continues to advance its technologies to meet diverse medical needs.
Impossible Cloud
Pre Seed Round in 2022
Impossible Cloud offers a decentralized, enterprise-grade cloud platform leveraging web3 technology. It provides faster, cheaper, and more secure multi-service solutions compared to traditional hyperscalers and on-premises private clouds. Backed by a fiat-based payment system, it caters to B2B customers without requiring cryptocurrency transactions. The platform ensures 100% durability and availability with almost unlimited storage capacity and no hidden costs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.